TY - JOUR
T1 - A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway
AU - Raju, Rajesh
AU - Balakrishnan, Lavanya
AU - Nanjappa, Vishalakshi
AU - Bhattacharjee, Mitali
AU - Getnet, Derese
AU - Muthusamy, Babylakshmi
AU - Thomas, Joji Kurian
AU - Sharma, Jyoti
AU - Rahiman, B. Abdul
AU - Harsha, H. C.
AU - Shankar, Subramanian
AU - Prasad, T. S.Keshava
AU - Mohan, S. Sujatha
AU - Bader, Gary D.
AU - Wani, Mohan R.
AU - Pandey, Akhilesh
PY - 2011
Y1 - 2011
N2 - Receptor activator of nuclear factor-kappa B ligand (RANKL) is a member of tumor necrosis factor (TNF) superfamily that plays a key role in the regulation of differentiation, activation and survival of osteoclasts and also in tumor cell migration and bone metastasis. Osteoclast activation induced by RANKL regulates hematopoietic stem cell mobilization as part of homeostasis and host defense mechanisms thereby linking regulation of hematopoiesis with bone remodeling. Binding of RANKL to its receptor, Receptor activator of nuclear factor-kappa B (RANK) activates molecules such as NF-kappa B, mitogen activated protein kinase (MAPK), nuclear factor of activated T cells (NFAT) and phosphatidyl 3-kinase (PI3K). Although the molecular and cellular roles of these molecules have been reported previously, a systematic cataloging of the molecular events induced by RANKL/RANK interaction has not been attempted. Here, we present a comprehensive reaction map of the RANKL/RANK-signaling pathway based on an extensive manual curation of the published literature. We hope that the curated RANKL/RANK-signaling pathway model would enable new biomedical discoveries, which can provide novel insights into disease processes and development of novel therapeutic interventions.
AB - Receptor activator of nuclear factor-kappa B ligand (RANKL) is a member of tumor necrosis factor (TNF) superfamily that plays a key role in the regulation of differentiation, activation and survival of osteoclasts and also in tumor cell migration and bone metastasis. Osteoclast activation induced by RANKL regulates hematopoietic stem cell mobilization as part of homeostasis and host defense mechanisms thereby linking regulation of hematopoiesis with bone remodeling. Binding of RANKL to its receptor, Receptor activator of nuclear factor-kappa B (RANK) activates molecules such as NF-kappa B, mitogen activated protein kinase (MAPK), nuclear factor of activated T cells (NFAT) and phosphatidyl 3-kinase (PI3K). Although the molecular and cellular roles of these molecules have been reported previously, a systematic cataloging of the molecular events induced by RANKL/RANK interaction has not been attempted. Here, we present a comprehensive reaction map of the RANKL/RANK-signaling pathway based on an extensive manual curation of the published literature. We hope that the curated RANKL/RANK-signaling pathway model would enable new biomedical discoveries, which can provide novel insights into disease processes and development of novel therapeutic interventions.
UR - http://www.scopus.com/inward/record.url?scp=80052901014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052901014&partnerID=8YFLogxK
U2 - 10.1093/database/bar021
DO - 10.1093/database/bar021
M3 - Article
C2 - 21742767
AN - SCOPUS:80052901014
SN - 1758-0463
VL - 2011
JO - Database
JF - Database
M1 - bar021
ER -